These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 18663770)

  • 1. Second-trimester sonographic soft markers: what can we learn from the experience of first-trimester nuchal translucency screening?
    Lau TK; Evans MI
    Ultrasound Obstet Gynecol; 2008 Aug; 32(2):123-5. PubMed ID: 18663770
    [No Abstract]   [Full Text] [Related]  

  • 2. Fetal thickened nuchal soft tissues may first appear in the second trimester in Down syndrome.
    Zimmer EZ; Blazer S; Linn S; Bronshtein M
    J Clin Ultrasound; 2010 Feb; 38(2):71-4. PubMed ID: 19830827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The history of the second-trimester sonographic markers for detecting fetal Down syndrome, and their current role in obstetric practice.
    Benacerraf BR
    Prenat Diagn; 2010 Jul; 30(7):644-52. PubMed ID: 20572106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technical aspects of nuchal translucency measurement.
    Abuhamad A
    Semin Perinatol; 2005 Dec; 29(6):376-9. PubMed ID: 16533650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuchal translucency-based Down syndrome screening: barriers to implementation.
    Malone FD
    Semin Perinatol; 2005 Aug; 29(4):272-6. PubMed ID: 16104681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Down syndrome screening by ultrasound].
    Rozenberg P
    Gynecol Obstet Fertil; 2005; 33(7-8):526-32. PubMed ID: 16005667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for Down syndrome using first-trimester ultrasound and second-trimester maternal serum markers in a low-risk population: a prospective longitudinal study.
    Audibert F; Dommergues M; Benattar C; Taieb J; Thalabard JC; Frydman R
    Ultrasound Obstet Gynecol; 2001 Jul; 18(1):26-31. PubMed ID: 11489221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nuchal translucency: this is not so simple!].
    Constant M
    Gynecol Obstet Fertil; 2014 Dec; 42(12):820-1. PubMed ID: 25456489
    [No Abstract]   [Full Text] [Related]  

  • 10. [Down syndrome screening in France: the worst consensus].
    Rozenberg P; Bussières L; Senat MV
    J Gynecol Obstet Biol Reprod (Paris); 2007 Apr; 36(2):95-103. PubMed ID: 17289296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuchal translucency screening in monochorionic twin pregnancies.
    Zoppi MA
    Ultrasound Obstet Gynecol; 2009 Nov; 34(5):491-3. PubMed ID: 19852038
    [No Abstract]   [Full Text] [Related]  

  • 12. Maintaining quality assurance for sonographic nuchal translucency measurement: lessons from the FASTER Trial.
    D'Alton ME; Cleary-Goldman J; Lambert-Messerlian G; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Berkowitz RL; Dar P; Dugoff L; Craigo SD; Timor IE; Carr SR; Wolfe HM; Dukes K; Canick JA; Malone FD
    Ultrasound Obstet Gynecol; 2009 Feb; 33(2):142-6. PubMed ID: 19173241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of first-trimester nuchal translucency on second-trimester maternal serum biochemical screening for Down's syndrome.
    Thilaganathan B; Slack A; Wathen NC
    Ultrasound Obstet Gynecol; 1997 Oct; 10(4):261-4. PubMed ID: 9383877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal nuchal translucency thickness.
    Witters I; Fryns JR
    Genet Couns; 2007; 18(1):1-7. PubMed ID: 17515296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automatic detection and measurement of nuchal translucency.
    Sciortino G; Tegolo D; Valenti C
    Comput Biol Med; 2017 Mar; 82():12-20. PubMed ID: 28126630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic sonography after first-trimester Down syndrome screening.
    Krantz DA; Hallahan TW; Macri VJ; Macri JN
    Ultrasound Obstet Gynecol; 2007 Jun; 29(6):666-70. PubMed ID: 17492748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal anxiety about first trimester nuchal translucency screening and impact of positive screening results.
    Chueh HY; Cheng PJ; Shaw SW; Lin CT; Hsu JJ; Hsieh TT
    Acta Obstet Gynecol Scand; 2007; 86(12):1437-41. PubMed ID: 17851819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of nuchal translucency measurement on second-trimester biochemical screening for Down's syndrome.
    Kadir RA; Economides DL
    Ultrasound Obstet Gynecol; 1997 Apr; 9(4):244-7. PubMed ID: 9168574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuchal translucency measurement in first trimester Down syndrome screening.
    Scott A
    Issues Emerg Health Technol; 2007 Jun; (100):1-6. PubMed ID: 17595751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of nuchal translucency screening on anxiety and depression levels in pregnancy and puerperium.
    Rustico MA; Nicolini U
    Ultrasound Obstet Gynecol; 2006 Apr; 27(4):356. PubMed ID: 16565997
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.